Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 Studies

Keratoconjunctivitis sicca affects 5% to 33% of the population and is often accompanied by symptoms such as burning and dryness. This pooled analysis evaluated total and central corneal fluorescein staining (CFS) in patients receiving OTX-101 0.09% or vehicle in phase 2b/3 and 3 studies and whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Malhotra, Ranjan, Devries, Douglas K., Luchs, Jodi, Kabat, Alan, Schechter, Barry A., Shen Lee, Bridgitte, Shettle, Lee, Smyth-Medina, Robert, Ogundele, Abayomi, Darby, Charles, Bacharach, Jason, Karpecki, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cornea 2019
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749965/
https://www.ncbi.nlm.nih.gov/pubmed/31306284
http://dx.doi.org/10.1097/ICO.0000000000001989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749965/
https://www.ncbi.nlm.nih.gov/pubmed/31306284
http://dx.doi.org/10.1097/ICO.0000000000001989

Ejemplares similares